Meeting
2020 ASCO Virtual Scientific Program
Safety and efficacy of single-agent adjuvant trastuzumab in older women with early-stage breast cancer.
Authors
Cynthia Owusu
Case Western Reserve University School of Medicine, Cleveland, OH
Cynthia Owusu , Seunghee P Margevicius , Heidi D. Klepin , Charles L. Vogel , Asrar Alahmadi , Sowjanya Vuyyala , Adam Brufsky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
NCT00796978
Citation
J Clin Oncol 38: 2020 (suppl; abstr 528)
DOI
10.1200/JCO.2020.38.15_suppl.528
Abstract #
528
Poster Bd #
20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
First Author: Lichen Tang
Poster
2023 ASCO Genitourinary Cancers Symposium
Efficacy and safety of docetaxel (D) vs androgen-receptor signaling inhibitors (ARSi) as second-line therapy (Rx) after progression on alternative ARSi as first-line Rx for patients who are elderly (≥75 years old) with metastatic castration-resistant prostate cancer (mCRPC) in a multicenter international database: A SPARTACUSS–Meet-URO 26 study.
First Author: Vincenzo Gennusa
Poster
2022 ASCO Annual Meeting
Associations between axillary staging, adjuvant treatment, and survival in older women with early-stage breast cancer: A population-based study.
First Author: Matthew Castelo
Poster
2021 Genitourinary Cancers Symposium
Efficacy and safety of avelumab plus axitinib (A + Ax) versus sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101.
First Author: Yoshihiko Tomita